ArticleInvestigative ophthalmology & visual science2025
Association Between Chronic Kidney Disease and Glaucoma: Results From the Lifelines Cohort Study and UK Biobank.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between Circulating Ketone Bodies and Primary Open-Angle Glaucoma and Related Ocular Parameters.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Chronic kidney disease (CKD) and glaucoma are major health burdens, yet their phenotypic and genotypic relationships remain poorly understood. This population-based study aims to explore the phenotypic and genotypic relationship between CKD and glaucoma. Methods: In this cross-sectional study, European-descended individuals aged 55 years + from the Lifelines Cohort (n = 21,475; 906 CKD cases) and UK Biobank (n = 90,133; 3323 CKD cases) were analyzed. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m². In Lifelines, glaucoma was defined using a previously established algorithm, which integrated self-reported glaucoma diagnosis and treatment with NEI-VFQ-25 scores. In the UK Biobank, primary open angle glaucoma cases were identified using a combination of self-reported diagnoses, treatment history, and International Classification of Diseases (ICD) codes. Logistic regression assessed the phenotypic association of CKD and eGFR with glaucoma, adjusting for demographic and clinical factors. Genetic analysis included linkage disequilibrium score regression (LDSR), polygenic risk scores (PRS), and Mendelian randomization (MR). Results: The prevalence of glaucoma was 8.2% in Lifelines and 5.5% in the UK Biobank. In Lifelines, no association between eGFR and glaucoma was found, but eGFR quintile 5 showed increased odds of glaucoma when excluding possible cases (odds ratio [OR] = 1.58, 95% confidence interval [CI] = 1.07-2.23, P = 0.02). In the UK Biobank, per 10 mL/min/1.73 m² eGFR increase was associated with higher odds of glaucoma (OR = 1.04, 95% CI = 1.02-1.07, P = 0.001), and quintile 5 exhibited increased odds regardless of whether all cases were included (OR = 1.14, 95% CI = 1.03-1.25, P = 0.01) or possible cases were excluded (OR = 1.13, 95% CI = 1.02-1.25, P = 0.02). No significant associations were found between CKD and glaucoma. LDSR showed no genetic correlations, but PRS indicated a significant association between glaucoma PRS and higher eGFR. MR revealed no causal relationship between eGFR and glaucoma. Conclusions: No association was found between CKD and glaucoma, but higher eGFR was associated with increased odds of glaucoma. These findings challenge the assumed link between low eGFR and glaucoma and highlight the need for further research into the underlying mechanisms and potential clinical implications of this association.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.